Fat mass and obesity-associated gene polymorphisms do not affect metabolic response to hormone therapy in healthy postmenopausal women

European Journal of Obstetrics and Gynecology and Reproductive Biology

Volumn 165, Issue 2, 2012, Pages 302-306

  Ramos, Ramon B ^a,b   Casanova, Gislaine K ^a,b   Spritzer, Poli M ^a,b,c  

^a HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

^b National Institute of Hormones and Women's Health   (Brazil)

^c FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

Central obesity; FTO gene; Lipid accumulation product; Postmenopausal hormone replacement therapy; Postmenopause

Indexed keywords

C REACTIVE PROTEIN; CHOLESTEROL; DROSPIRENONE; ESTRADIOL; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ANTHROPOMETRY; ARTICLE; BLOOD PRESSURE; BLOOD SAMPLING; BODY MASS; CHOLESTEROL BLOOD LEVEL; CROSSOVER PROCEDURE; ESTROGEN DEFICIENCY; FEMALE; FOLLOW UP; GENOTYPE; GLUCOSE BLOOD LEVEL; HAPLOTYPE; HORMONAL THERAPY; HUMAN; LIPID STORAGE; MAJOR CLINICAL STUDY; OBESITY; ORAL GLUCOSE TOLERANCE TEST; POSTMENOPAUSE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; REAL TIME POLYMERASE CHAIN REACTION; SINGLE NUCLEOTIDE POLYMORPHISM; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE;

EID: 84870295421     PISSN: 03012115     EISSN: 18727654     Source Type: Journal    
DOI: 10.1016/j.ejogrb.2012.07.024     Document Type: Article

References (37)

1. T.S. Mikkola, and T.B. Clarkson Estrogen replacement therapy, atherosclerosis, and vascular function Cardiovascular Research 53 2002 605 619
2. C.A. Derby, S.L. Crawford, R.C. Pasternak, M. Sowers, B. Sternfeld, and K.A. Matthews Lipid changes during the menopause transition in relation to age and weight: the study of women's health across the nation American Journal of Epidemiology 169 2009 1352 1361
3. J.A. Kanaley, C. Sames, and L. Swisher Abdominal fat distribution in pre- and postmenopausal women: the impact of physical activity, age, and menopausal status Metabolism: Clinical and Experimental 50 2001 976 982
4. S. Hulley, D. Grady, and T. Bush Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/Progestin Replacement Study (Hers) Research Group JAMA: The Journal of the American Medical Association 280 1998 605 613
5. A.D. Pradhan, J.E. Manson, and J.E. Rossouw Inflammatory biomarkers, hormone replacement therapy, and incident coronary heart disease: prospective analysis from the Women's Health Initiative observational study JAMA: The Journal of the American Medical Association 288 2002 980 987
6. S.M. Harman, E. Vittinghoff, and E.A. Brinton Timing and duration of menopausal hormone treatment may affect cardiovascular outcomes American Journal of Medicine 124 2011 199 205
7. Y. Song, N.C. You, and Y.H. Hsu FTO polymorphisms are associated with obesity but not diabetes risk in postmenopausal women Obesity (Silver Spring) 16 2008 2472 2480
8. R.B. Ramos, G.K. Casanova, M.A. Maturana, and P.M. Spritzer Variations in the fat mass and obesity-associated (FTO) gene are related to glucose levels and higher lipid accumulation product in postmenopausal women from southern Brazil Fertility and Sterility 96 2011 974 979
9. M.J. Taverna, M.T. Martinez-Larrad, G.D. Frechtel, and M. Serrano-Rios Lipid accumulation product: a powerful marker of metabolic syndrome in healthy population European Journal of Endocrinology/European Federation of Endocrine Societies 164 2011 559 567
10. H.S. Kahn The "lipid accumulation product" performs better than the body mass index for recognizing cardiovascular risk: a population-based comparison BMC Cardiovascular Disorders 5 2005 26
11. G. Casanova, S. Radavelli, F. Lhullier, and P.M. Spritzer Effects of nonoral estradiol-micronized progesterone or low-dose oral estradiol- drospirenone therapy on metabolic variables and markers of endothelial function in early postmenopause Fertility and Sterility 92 2009 605 612
12. M. Toscani, R. Migliavacca, J.A. Sisson de Castro, and P.M. Spritzer Estimation of truncal adiposity using waist circumference or the sum of trunk skinfolds: a pilot study for insulin resistance screening in hirsute patients with or without polycystic ovary syndrome Metabolism: Clinical and Experimental 56 2007 992 997
13. A.V. Chobanian, G.L. Bakris, and H.R. Black The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report JAMA: The Journal of the American Medical Association 289 2003 2560 2572
14. W.T. Friedewald, R.I. Levy, and D.S. Fredrickson Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge Clinical Chemistry 18 1972 499 502
15. S.A. Miller, D.D. Dykes, and H.F. Polesky A simple salting out procedure for extracting DNA from human nucleated cells Nucleic Acids Research 16 1988 1215
16. P.W. Hedrick Gametic disequilibrium measures: proceed with caution Genetics 117 1987 331 341
17. R.C. Lewontin On measures of gametic disequilibrium Genetics 120 1988 849 852
18. M. Stephens, N.J. Smith, and P. Donnelly A new statistical method for haplotype reconstruction from population data American Journal of Human Genetics 68 2001 978 989
19. J.E. Manson, M.A. Allison, and J.E. Rossouw Estrogen therapy and coronary-artery calcification New England Journal of Medicine 356 2007 2591 2602
20. J.E. Rossouw, R.L. Prentice, and J.E. Manson Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause JAMA: The Journal of the American Medical Association 297 2007 1465 1477
21. S.R. Salpeter, J. Cheng, L. Thabane, N.S. Buckley, and E.E. Salpeter Bayesian meta-analysis of hormone therapy and mortality in younger postmenopausal women American Journal of Medicine 122 2009 1016-22 e1
22. R.J. Norman, I.H. Flight, and M.C. Rees Oestrogen and progestogen hormone replacement therapy for peri-menopausal and post-menopausal women: weight and body fat distribution Cochrane Database of Systematic Reviews 2000 CD001018
23. M. Hemelaar, M.J. van der Mooren, W.M. van Baal, C.G. Schalkwijk, P. Kenemans, and C.D. Stehouwer Effects of transdermal and oral postmenopausal hormone therapy on vascular function: a randomized, placebo-controlled study in healthy postmenopausal women Menopause 12 2005 526 535
24. S.R. Salpeter, J.M. Walsh, T.M. Ormiston, E. Greyber, N.S. Buckley, and E.E. Salpeter Meta-analysis: effect of hormone-replacement therapy on components of the metabolic syndrome in postmenopausal women Diabetes, Obesity and Metabolism 8 2006 538 554
25. T.M. Frayling, N.J. Timpson, and M.N. Weedon A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity Science 316 2007 889 894
26. K. Hotta, Y. Nakata, and T. Matsuo Variations in the FTO gene are associated with severe obesity in the Japanese Journal of Human Genetics 53 2008 546 553
27. E. Wehr, S. Pilz, B.O. Boehm, W. Marz, and B. Obermayer-Pietsch The lipid accumulation product is associated with increased mortality in normal weight postmenopausal women Obesity (Silver Spring) 19 2011 1873 1880
28. M. Bozorgmanesh, F. Hadaegh, and F. Azizi Predictive performances of lipid accumulation product vs. adiposity measures for cardiovascular diseases and all-cause mortality, 8.6-year follow-up: Tehran lipid and glucose study Lipids in Health and Disease 9 2010 100
29. M.A. Maturana, R.M. Moreira, and P.M. Spritzer Lipid accumulation product (LAP) is related to androgenicity and cardiovascular risk factors in postmenopausal women Maturitas 70 2011 395 399
30. T. Gerken, C.A. Girard, and Y.C. Tung The obesity-associated FTO gene encodes a 2-oxoglutarate-dependent nucleic acid demethylase Science 318 2007 1469 1472
31. S. Peng, Y. Zhu, F. Xu, X. Ren, X. Li, and M. Lai FTO gene polymorphisms and obesity risk: a meta-analysis BMC Medicine 9 2011 71
32. B. Xi, and J. Mi FTO polymorphisms are associated with obesity but not with diabetes in East Asian populations: a meta-analysis Biomedical and Environmental Sciences 22 2009 449 457
33. T.O. Kilpelainen, L. Qi, and S. Brage Physical activity attenuates the influence of FTO variants on obesity risk: a meta-analysis of 218,166 adults and 19,268 children PLoS Medicine 8 2011 e1001116
34. L.G. Grunnet, C. Brons, and S. Jacobsen Increased recovery rates of phosphocreatine and inorganic phosphate after isometric contraction in oxidative muscle fibers and elevated hepatic insulin resistance in homozygous carriers of the A-allele of FTO rs9939609 Journal of Clinical Endocrinology and Metabolism 94 2009 596 602
35. M. Hakanen, O.T. Raitakari, and T. Lehtimaki FTO genotype is associated with body mass index after the age of seven years but not with energy intake or leisure-time physical activity Journal of Clinical Endocrinology and Metabolism 94 2009 1281 1287
36. J.A. Mitchell, T.S. Church, T. Rankinen, C.P. Earnest, X. Sui, and S.N. Blair FTO genotype and the weight loss benefits of moderate intensity exercise Obesity (Silver Spring) 18 2010 641 643
37. T. Ahmad, D.I. Chasman, and S. Mora The fat-mass and obesity-associated (FTO) gene, physical activity, and risk of incident cardiovascular events in white women American Heart Journal 160 2010 1163 1169